It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2001-2002. During the financial year, The Company’s Total Income Rs. 7590 million. Net Profit after Tax for the year Rs. 1686 million. Total income increased 22.2%, net profit increased 24.8% over last year. The domestic formulations business, the company’s largest contributor to turnover, grew by 26% to Rs. 4661 million. Preference Share Rs. 14. Equity shares intern Rs. 234.
The Board of Directors is pleased to recommend an equity dividend @50% for the year ended 31st March 2002 (previous year @50%) on the equity share capital.
More Annual Report of Sun Pharmaceutical Industries Limited:
- Annual Report 1999-2000 of Sun Pharmaceutical Industries Limited
- Annual Report 2000-2001 of Sun Pharmaceutical Industries Limited
- Annual Report 2001-2002 of Sun Pharmaceutical Industries Limited
- Annual Report 2002-2003 of Sun Pharmaceutical Industries Limited
- Annual Report 2003-2004 of Sun Pharmaceutical Industries Limited
- Annual Report 2004-2005 of Sun Pharmaceutical Industries Limited
- Annual Report 2005-2006 of Sun Pharmaceutical Industries Limited
- Annual Report 2006-2007 of Sun Pharmaceutical Industries Limited
- Annual Report 2007-2008 of Sun Pharmaceutical Industries Limited
- Annual Report 2008-2009 of Sun Pharmaceutical Industries Limited
- Annual Report 2009-2010 of Sun Pharmaceutical Industries Limited
- Annual Report 2010-2011 of Sun Pharmaceutical Industries Limited
- Annual Report 2011-2012 of Sun Pharmaceutical Industries Limited
- Annual Report 2012-2013 of Sun Pharmaceutical Industries Limited
- Annual Report 2013-2014 of Sun Pharmaceutical Industries Limited
- Annual Report 2014-2015 of Sun Pharmaceutical Industries Limited
- Annual Report 2015-2016 of Sun Pharmaceutical Industries Limited
- Annual Report 2016-2017 of Sun Pharmaceutical Industries Limited
